CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405S conjugate, 0.1mg/mL, Clone: [HuLy-m2], Mouse, Monoclonal

Artikelnummer: BOT-BNC041252-500
Artikelname: CD7 (T-Cell Leukemia Marker)(HuLy-m2), CF405S conjugate, 0.1mg/mL, Clone: [HuLy-m2], Mouse, Monoclonal
Artikelnummer: BOT-BNC041252-500
Hersteller Artikelnummer: BNC041252-500
Alternativnummer: BOT-BNC041252-500-500UL
Hersteller: Biotium
Wirt: Mouse
Kategorie: Antikörper
Applikation: IF
Spezies Reaktivität: Human
Immunogen: Human thymocytes
Konjugation: CF405S
Alternative Synonym: GP40, Leu9, p41, T-cell leukemia antigen, T-cell surface antigen Leu-9, Tp40, TP41
Recognizes a protein of 40 kDa, identified as CD7 (Workshop IV, Code T165). CD7 is a member of the immunoglobulin gene superfamily. Its N-terminal amino acids 1-107 are highly homologous to Ig kappa-L chains whereas the carboxyl-terminal region of the extracellular domain is proline-rich and has been postulated to form a stalk from which the Ig domain projects. CD7 is expressed on the majority of immature and mature T-lymphocytes, and T cell leukemia. It is also found on natural killer cells, a small subpopulation of normal B cells and on malignant B cells. Cross-linking surface CD7 positively modulates T cell and NK cell activity as measured by calcium fluxes, expression of adhesion molecules, cytokine secretion and proliferation. CD7 associates directly with phosphoinositol 3-kinase. CD7 ligation induces production of D-3 phosphoinositides and tyrosine phosphorylation.
Klonalität: Monoclonal
Konzentration: 0.1 mg/mL
Klon-Bezeichnung: [HuLy-m2]
Molekulargewicht: 40 kDa
UniProt: P09564
Puffer: PBS, 0.1% BSA, 0.05% azide
Quelle: Animal
Anwendungsbeschreibung: Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody|Flow cytometry: 0.5-1 ug/million cells|Immunofluorescence: 0.5-1 ug/mL|Optimal dilution for a specific application should be determined by user